V

Vitestro

Autonomous robotic venipuncture device for labs

Medior C++ Software Engineer

Embedded EngineeringUpdated on Nov 13
Full-timeUtrecht, NetherlandsNo salary listedIn-person

About the Job

Responsibilities

  • Design, implement, and improve robust C++ software that interacts with multiple subsystems and real-time environments.
  • Collaborate with hardware engineers, systems engineers, and other software developers to ensure system reliability, maintainability, and performance.
  • Contribute to software design, implementation, and improvement in modern C++ (C++17/20).
  • Contribute to debugging, automated testing, and code reviews.
  • Work on new features in the scope of the motion team.
  • Solve complex integration issues arising from production and field use.
  • Improve existing software architecture, including maintainability, scalability, and performance.
  • Design and maintain structured state-machine-based logic.
  • Integrate evolving hardware components into the software stack.
  • Contribute to system-level design discussions and technical decisions.
  • Debug complex issues across software and hardware boundaries.
  • Improve testability and automated verification strategies.
  • Participate in code reviews and help raise software quality standards.
  • Own significant features and parts of the team's codebase, including implementation knowledge of the motion software unit, accuracy calibrations, and verifications.
  • Help build the engineering roadmap for the coming years.

About the Company

Vitestro

Autonomous robotic venipuncture device for labs

Vitestro creates autonomous phlebotomy systems for high-volume outpatient settings. Its Aletta device uses multimodal imaging, robotic needle guidance and AI to locate a suitable vein, insert the needle and collect diagnostic blood samples without human intervention. The system standardizes the blood-drawing process to improve consistency, reduce staffing pressure and enhance patient experience, while pursuing regulatory approval paths (FDA De Novo in the US and European deployments) and expanding manufacturing and commercialization. The company differentiates itself through a CE-marked autonomous robotic phlebotomy platform backed by collaborations with major healthcare partners (Labcorp Venture Fund, Mayo Clinic, Sutter Health) and a focus on scalable, high-throughput blood collection. Its goal is to enable safer, reliable and efficient outpatient phlebotomy at scale.

Company size
51-200
Company stage
Series B
Total funding
$107.3M
Headquarters
Utrecht, Netherlands
Founded
2017

Recently Posted Jobs

Explore more opportunities at Vitestro

See more jobs